1.2 Fetal Surveillance & Antepartum Diagnostics

1.2 Fetal Surveillance & Antepartum Diagnostics

Antenatal Diagnostic Testing & Fetal Surveillance

Evaluating fetal well-being in utero guides the timing of delivery and identifies neonates requiring advanced resuscitation equipment at birth.

Non-Stress Test (NST)

The NST monitors the fetal heart rate (FHR) response to spontaneous fetal movement using external Doppler ultrasound and tocodynamometry:

• Reactive NST (Reassuring / Normal): In pregnancies $\ge 32\text{ weeks}$, presence of $\ge 2$ fetal heart rate accelerations of at least $15\text{ bpm}$ above the baseline, lasting at least $15\text{ seconds}$ ($15\times 15\text{ criterion}$), within a 20-minute monitoring window. In fetuses $<32\text{ weeks}$, accelerations of $\ge 10\text{ bpm}$ lasting $\ge 10\text{ seconds}$ ($10\times 10\text{ criterion}$) are considered reactive.
• Non-Reactive NST (Non-Reassuring / Abnormal): Absence of sufficient accelerations over a 40-minute testing period. A nonreactive NST can reflect sleep, prematurity, medication exposure, hypoxemia, or acidemia and requires further obstetric assessment; the next test and timing depend on gestational age and the clinical context.

Biophysical Profile (BPP)

The BPP combines the NST with real-time ultrasound imaging to score five distinct parameters. Each parameter is assigned either 2 points (normal/present) or 0 points (abnormal/absent) over a 30-minute observation window. The maximum achievable score is 10 points.

+-------------------------------------------------------------------------+
|                   BIOPHYSICAL PROFILE (BPP) COMPONENTS                  |
+------------------------------------+------------------------------------+
| 1. Fetal Breathing Movements (FBM) | >= 1 episode of sustained rhythmic |
|                                    | breathing >= 30 seconds duration   |
+------------------------------------+------------------------------------+
| 2. Gross Fetal Body Movements      | >= 3 discrete body/limb movements  |
+------------------------------------+------------------------------------+
| 3. Fetal Muscle Tone               | >= 1 episode of active extension   |
|                                    | with rapid return to flexion       |
+------------------------------------+------------------------------------+
| 4. Amniotic Fluid Volume (AFV)     | >= 1 vertical pocket >= 2.0 cm     |
|                                    | (or Amniotic Fluid Index > 5.0 cm) |
+------------------------------------+------------------------------------+
| 5. Non-Stress Test (NST)           | Reactive result (>= 2 accels)      |
+------------------------------------+------------------------------------+

Clinical Interpretation of BPP Scores

• Score 8/10 (with normal fluid) or 10/10: Generally reassuring. Continue management appropriate to the pregnancy and the indication for testing.
• Score 8/10 with Oligohydramnios: The low fluid remains important even when the other components are reassuring; it prompts closer surveillance and consideration of delivery according to gestational age and the maternal-fetal picture.
• Score 6/10: Equivocal. Repeat assessment within the time specified by the obstetric team or consider delivery based on gestational age and associated findings.
• Score $\le 4/10$: Abnormal and requires prompt obstetric evaluation and additional testing. Delivery may be indicated early or immediately, but the score alone neither proves asphyxia nor overrides gestational age, fluid status, fetal monitoring, and maternal condition.

Amniocentesis for Fetal Lung Maturity (FLM)

When preterm delivery is contemplated, amniotic fluid obtained via transabdominal amniocentesis can be analyzed to assess biochemical pulmonary maturity:

1. Lecithin-to-Sphingomyelin (L/S) Ratio:

   • Lecithin (Dipalmitoylphosphatidylcholine): The primary surface tension-lowering phospholipid of surfactant, which rises exponentially after 34 to 35 weeks gestation.
   • Sphingomyelin: A membrane phospholipid that remains relatively constant throughout late gestation, serving as an internal reference standard.
   • Interpretation: An L/S ratio around 2 or greater has historically suggested lower RDS risk, while a low ratio increases concern for immaturity. The test is probabilistic rather than a guarantee.
   • Diabetes: Maternal diabetes can delay functional surfactant maturation and weaken the reassurance provided by an apparently mature ratio. Do not apply a single universal higher cutoff; integrate phosphatidylglycerol, gestational age, maternal control, and the newborn’s condition.

2. Phosphatidylglycerol (PG):

   • A minor phospholipid (comprising $\sim 10%$ of mature surfactant) that stabilizes the alveolar phospholipid monolayer at low lung volumes.
   • PG appears late in gestation, typically at 35 to 36 weeks.
   • Interpretation: Detectable PG supports advancing lung maturity and is less affected than the L/S ratio by some common contaminants. It is not perfectly sensitive or an absolute guarantee against RDS; specimen quality and the clinical context still matter.

3. Lamellar Body Count (LBC):

   • Lamellar bodies are the intracellular storage packets of surfactant produced by type II pneumocytes. They are similar in size to platelets and can be enumerated rapidly using a standard hematology counter.
   • Higher lamellar-body counts generally support advancing maturity and very low counts raise concern for RDS, but cutoffs are analyzer-, specimen-, and laboratory-specific. Use the reporting laboratory's validated interpretation rather than a universal 15,000/50,000 per microliter rule.

---

Worked Clinical Case: Evaluating an Equivocal Antenatal Profile

A 32-year-old Gravida 2, Para 1 female at 35 weeks gestation presents with decreased fetal movements over the preceding 24 hours. Ultrasonographic observation over 30 minutes reveals:

• Absence of sustained fetal breathing movements (continuous apnea observed): 0 points
• Four discrete limb movements with rolling of the torso: 2 points
• The fetus actively opens its hand and promptly clenches it back into a fist: 2 points
• The largest measurable vertical pocket of amniotic fluid is $1.1\text{ cm}$: 0 points
• The 20-minute NST demonstrates a baseline of $140\text{ bpm}$ with only one acceleration of $15\text{ bpm}$ lasting $15\text{ seconds}$: 0 points

Total BPP Score: $2 + 2 = 4/10$. Clinical Decision: A BPP of 4 with oligohydramnios is abnormal and requires immediate obstetric assessment. At 35 weeks, the team should prepare for possible urgent delivery while the obstetric service integrates fetal monitoring, maternal status, and the full clinical picture; the score alone does not prove asphyxia or mandate one delivery route.

---

NPS Exam Traps

Exam Trap 1: The "Mature" L/S Ratio in an Infant of a Diabetic Mother

An apparently mature L/S ratio is less reassuring when maternal diabetes is poorly controlled. Treat the result as one risk estimate, not permission to dismiss grunting, retractions, tachypnea, oxygen need, or a radiographic pattern of RDS.

Exam Trap 2: Magnesium Sulfate vs. Opioid Respiratory Depression

When an infant is born limp, apneic, and hyporeflexic after maternal magnesium therapy, naloxone does not reverse magnesium exposure and is not the resuscitation priority. Establish effective positive-pressure ventilation (PPV) with an appropriate neonatal device, follow the heart-rate response, and evaluate glucose, temperature, medications, infection, and other causes while the neonatal team manages any clinically important magnesium toxicity.

Exam Trap 3: Fluid Contamination in Amniocentesis

Blood, meconium, or vaginal-fluid contamination can distort biochemical lung-maturity testing. PG may be less vulnerable than the L/S ratio to some contaminants, but verify specimen quality and avoid calling any result completely reliable in isolation.